
| Salt Composition: | Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg) |
| Manufacturer: | Wings Biotech Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Glimixia-VM2 Tablet ER is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. Glimixia-VM2 Tablet ER is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Glimixia-VM2 Tablet ER is a combination of three antidiabetic medicines:
What is Glimixia-VM2 Tablet ER?
Glimixia-VM2 Tablet ER is a combination medication containing Glimepiride, Metformin, and Voglibose. This medicine is used to manage type 2 diabetes mellitus (DM). It works by improving blood glucose levels in adults when taken along with a healthy diet and regular exercise.
What are the possible side effects of Glimixia-VM2 Tablet ER?
Common side effects include hypoglycemia (low blood sugar), nausea, diarrhea, changes in taste perception, flatulence, stomach pain, headaches, skin rash, and respiratory tract infection. If you experience any unusual symptoms, contact your doctor or healthcare provider immediately.
Are there any specific conditions where Glimixia-VM2 Tablet ER should not be taken?
It's essential to avoid this medication if you have known allergies to any component or excipient. Additionally, it should not be used in individuals with moderate to severe kidney disease, inflammatory bowel disease (IBD), colonic ulcerations, or underlying metabolic acidosis including diabetic ketoacidosis.
Is it safe to take alcohol while taking Glimixia-VM2 Tablet ER?
No, consuming alcohol with Glimixia-VM2 Tablet ER is not recommended. It may lower your blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Can Glimixia-VM2 Tablet ER cause hypoglycemia?
Yes, Glimixia-VM2 Tablet ER can cause hypoglycemia (low blood sugar levels). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This risk increases with skipping meals, consuming alcohol, overexertion, or taking other antidiabetic medications simultaneously.
What are the instructions for storing and disposing of Glimixia-VM2 Tablet ER?
Store this medication in its original packaging, tightly closed. Follow the storage instructions on the package label. Do not consume leftover medication. Ensure it is kept out of reach of pets, children, and other individuals.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimixia-VM2 Tablet ER is to be taken empty stomach.
Alcohol
It is unsafe to consume alcohol with Glimixia-VM2 Tablet ER.
Breastfeed
Glimixia-VM2 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Glimixia-VM2 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.